Reuters logo
BRIEF-Pain Therapeutics announces positive regulatory guidance for Remoxy ER
March 21, 2017 / 12:58 AM / 6 months ago

BRIEF-Pain Therapeutics announces positive regulatory guidance for Remoxy ER

March 20 (Reuters) - Pain Therapeutics Inc

* Pain Therapeutics announces positive regulatory guidance for Remoxy ER

* Believe its now on track to make expeditious progress toward resubmission of Remoxy NDA

* Pain Therapeutics Inc - expect to complete remoxy studies by year-end 2017, at a cost of approximately $3 mln-$4 mln

* Agreement reached with FDA on additional studies that are needed for Remoxy’s approval Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below